BioNTech (BNTX) total liabilities

Total liabilities · fiscal 2025
€2.76B

BioNTech (BNTX) had total liabilities of €2.76B at the end of fiscal 2025 (December 31, 2025). That is 11.4% lower than the €3.12B of fiscal 2024. Figures as of 19 Nov 2026, 02:44 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
€2.76B
Change on fiscal 2024
−11.4%
Highest on record
€3.22Bfiscal 2022
Lowest on record
€2.76Bfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

BioNTech total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €3.22B in fiscal 2022 and the lowest €2.76B in fiscal 2023.

History · 4 fiscal years

Total liabilities by fiscal year

BioNTech total liabilities, year by year

BioNTech (BNTX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025€2.76B 11.4% down
2024€3.12B 13.0% up
2023€2.76B 14.4% down
2022€3.22B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of BioNTech and comparable companies
CompanyTotal liabilitiesFiscal year
BioNTech BNTX€2.76B2025
Zimmer Biomet Holdings ZBH$10.39B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech total liabilities: questions and answers

How large are BioNTech's total liabilities?

BioNTech (BNTX) had total liabilities of €2.76B at the end of fiscal 2025 (December 31, 2025). That is 11.4% lower than the €3.12B of fiscal 2024.

What are the highest and lowest total liabilities figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was €3.22B in fiscal 2022 and the lowest €2.76B in fiscal 2023.

How is BioNTech's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For BioNTech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/BNTX/total-liabilities

Underlying data: Yahoo Finance.